Home » Topics » Disease categories and therapies » Infection

Infection
RSS

MedImmune receives patent coverage for RespiGam

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

BMS in-licenses antifungal triazole from Eisai

Dec. 13, 1996

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...